13 research outputs found
ANALYSIS OF TOBACCO PRODUCTION ON THE FAMILY FARM DUMANÄIÄ FROM 2012 TO 2014
U radu je analizirana proizvodnja duhana za razdoblje od 2012. do 2014. godine. IstraÅ£ivanja o vaÅ£nijim tehnoloÅ”kim Äiniteljima proizvodnje i ekonomskim pokazateljima obavljena su na OPG DumanÄiÄ iz Kutjeva. Cilj istraÅ£ivanja bio je utvrditi tehnoloÅ”ke Äinitelje i izraÄunati ekonomske rezultate u proizvodnji duhana. Temeljem prikupljenih knjigovodstvenih podataka izraÄene su trogodiÅ”nje analitiÄke kalkulacije u kojima su prikazani prihodi, troÅ”kovi i financijski rezultat. ProsjeÄna proizvodnost rada iznosi 5,45 kg po satu, te utroÅ”aka od 561,11 sati po toni. ProsjeÄni koeficijent ekonomiÄnosti proizvodnje iznosi 1,44 iz Äega je vidljivo da je proizvodnja duhana bila ekonomiÄna, a na 100 kn uloÅ£enih u proizvodnju ostvareno je prosjeÄno 44,38 kn dobiti.The paper analyzes the tobacco production in the period from 2012 to 2014. Research on important technological factors of production and economic indicators performed at OPG DumanÄiÄ from Kutjevo. The aim of this study was to determine the technological factors and calculate the economic results in the production of tobacco. Based on the collected accounting dana made a three-year analytical calculations that presents revenues, expenses an financial results. Average labor productivity is 5,45 kg per hour, and the consumption of 561,11 hours per ton. The average coefficient of economic production amounts to 1,44 from which it is clear that tobacco production was economical, and the 100 invested in production realized an average of 44,38 profit
ANALYSIS OF THE COSTS AND REVENUE OF TOBACCO PRODUCTION ON FAMILY FARMS DUMANÄIÄ
U radu je analizirana proizvodnja duhana za razdoblje od 2012. do 2016. godine. Istraživanja o važnijim tehnoloÅ”kim Äiniteljima proizvodnje i ekonomskim pokazateljima obavljena su na OPG DumanÄiÄ iz Kutjeva. Cilj istraživanja bio je utvrditi tehnoloÅ”ke Äinitelje i izraÄunati ekonomske rezultate u proizvodnji duhana. Temeljem prikupljenih internih i knjigovodstvenih podataka izraÄene su petogodiÅ”nje analitiÄke kalkulacije u kojima su obuhvaÄeni prihodi, troÅ”kovi te izraÄunat financijski rezultat. Analizom je utvrÄena dobit te ekonomiÄna i rentabilna proizvodnja duhana kroz razdoblje od pet godina. NajveÄa dobit ostvarena je u 2013. godini u iznosu od 5.950,65 kn/ha. NajveÄu stavku u strukturi prihoda ima poticaj, a u strukturi troÅ”kova rad ljudi.The paper analyzes the tobacco production in the period from 2012 to 2016. Research on important technological factors of production and economic indicators performed at OPG DumanÄiÄ from Kutjevo. The aim of this study was to determine the technological factors and calculate the economic results in the production of tobacco. Based on the collected accounting data made a three-year analytical calculations that presents revenues, expenses and financial results. The analysis has established profits and economical and profitable tobacco production over a period of five years. The highest gain was recorded in 2013 amount of 5.950 kn/ha. The biggest item in the income structure has an incentive and in the cost structure the work of people
Economic Efficiency of Tobacco Production: a Case Study
Proizvodnja duhana u Hrvatskoj odvija se pretežito na obiteljskim poljoprivrednim gospodarstvima. Pri istoj se primjenjuju i postupci suÅ”enja, pripreme i pakiranja za prodaju. Cilj rada bio je utvrditi ekonomsku uÄinkovitost proizvodnje duhana na OPG DumanÄiÄ iz Kutjeva za razdoblje od 2012. do 2016. godine. Temeljem prikupljenih podataka o tehnoloÅ”ko-ekonomskim Äiniteljima proizvodnje, naÄinjene su kalkulacije kao osnova za izraÄun pokazatelja uspjeÅ”nosti proizvodnje. NajveÄa dobit ostvarena je u 2013. godini u iznosu od 14.876,64 kn/ha. NajznaÄajniju stavku u strukturi prihoda ima poticaj, a u strukturi troÅ”kova rad ljudi. Vrijednosti ekonomskih pokazatelja, proizvodnost (4,53-1,57 kg/satu), ekonomiÄnost (1,31-1,57) i rentabilnost (31,16-56,69 %) ukazuju na ekonomski uÄinkovitu proizvodnju duhana na analiziranom gospodarstvu.Tobacco production in Croatia is predominantly carried out on family farms. The same applies to drying, preparation and packing for sale. The aim of this paper was to determine the economic efficiency of tobacco production at family farm DumanÄiÄ from Kutjevo for the period 2012-2016. Based on the collected data of technological and economic factors of production, calculations were made as a basis for defining production performance indicators. The highest profit was realized in 2013 in the amount of 14.876,64 HRK per hectare. Incentive was determined as the most significant item in the structure revenue and cost of labor in the structure. In the case of the analyzed family farm the values of economic indicators of productivity, economy and profitability point to an economically efficient production of tobacco
Economic Efficiency of Tobacco Production: a Case Study
Proizvodnja duhana u Hrvatskoj odvija se pretežito na obiteljskim poljoprivrednim gospodarstvima. Pri istoj se primjenjuju i postupci suÅ”enja, pripreme i pakiranja za prodaju. Cilj rada bio je utvrditi ekonomsku uÄinkovitost proizvodnje duhana na OPG DumanÄiÄ iz Kutjeva za razdoblje od 2012. do 2016. godine. Temeljem prikupljenih podataka o tehnoloÅ”ko-ekonomskim Äiniteljima proizvodnje, naÄinjene su kalkulacije kao osnova za izraÄun pokazatelja uspjeÅ”nosti proizvodnje. NajveÄa dobit ostvarena je u 2013. godini u iznosu od 14.876,64 kn/ha. NajznaÄajniju stavku u strukturi prihoda ima poticaj, a u strukturi troÅ”kova rad ljudi. Vrijednosti ekonomskih pokazatelja, proizvodnost (4,53-1,57 kg/satu), ekonomiÄnost (1,31-1,57) i rentabilnost (31,16-56,69 %) ukazuju na ekonomski uÄinkovitu proizvodnju duhana na analiziranom gospodarstvu.Tobacco production in Croatia is predominantly carried out on family farms. The same applies to drying, preparation and packing for sale. The aim of this paper was to determine the economic efficiency of tobacco production at family farm DumanÄiÄ from Kutjevo for the period 2012-2016. Based on the collected data of technological and economic factors of production, calculations were made as a basis for defining production performance indicators. The highest profit was realized in 2013 in the amount of 14.876,64 HRK per hectare. Incentive was determined as the most significant item in the structure revenue and cost of labor in the structure. In the case of the analyzed family farm the values of economic indicators of productivity, economy and profitability point to an economically efficient production of tobacco
Cerebellopontine angle tumors
Tumori pontocerebelarnog kuta Äine gotovo desetinu svih intrakranijskih tumora.
Zbog odreÄenih znaÄajki u kliniÄkoj slici i pristupu u lijeÄenju, ove Äe tumore mnogi autori svrstati
u zajedniÄku skupinu patologije u neurokirurgiji. Ove lezije predstavljaju poseban izazov u
dijagnostici i kirurÅ”kom lijeÄenju zbog specifiÄnog anatomskog smjeÅ”taja i vrlo raznolike etiologije.
UnatoÄ svojoj kompleksnosti, a sukladno rezultatima najnovijih kliniÄkih istraživanja, u modernoj
neurokirurgiji oÄekuje se uspjeÅ”no prepoznavanje kao i praÄenje progresije lezija pontocerebelarnog
kuta na temelju kliniÄke slike i visoko specifiÄnih neuroradioloÅ”kih i drugih metoda
diferencijalne dijagnostike. U konaÄnici kirurÅ”ko lijeÄenje dovodi do niskog morbiditeta i zanemarivog
mortaliteta operiranih bolesnika.Cerebellopontine angle tumors comprise almost 10 % of all intracranial tumors.
Due to their distinct clinical features and therapy approaches these tumors are listed within
the same neurosurgery pathological group. Such lesions represent a unique challenge in diagnostics
and surgical treatment which reflects their specific anatomic position and a large variety in etiology.
Despite the complexity of such tumors the most recent clinical research studies indicate
that modern neurosurgery can provide successful recognition and monitoring of cerebellopontine
angle lesion progression based on the clinical features and highly specific neuroradiological
and other diagnostic methods. Surgical treatment results in low morbidity and
minimal mortality rate of patients going through such surgery
Eritrocitoza u bolesnika na hemodijalizi lijeÄenog željeznom sukrozom
A 59-year-old Caucasian male started intermittent hemodialysis in March 1995 for the treatment of end-stage renal disease of unknown etiology. In December 2002, he started receiving parenteral iron sucrose, 100 mg every two weeks, for iron deficiency. He did not receive erythropoietin. One month later he experienced severe pruritus. Blood analysis revealed erythrocytosis. Iron therapy was discontinued immediately, and four venepunctures were performed to avoid thrombosis of AV fistula. Malignant disease was excluded. It was decided to apply an angiotensin convertase enzyme inhibitor (ACEi), ramipril, in a dose of 2.5 mg/day. However, the patient developed severe cough as a side effect of ramipril and was
switched to an angiotensin receptor type II antagonist (AAR), losartan, in a dose of 25 mg/day. While the patient was prone to hypotension during the dialysis sessions, losartan was administered every evening at bedtime. One month after the introduction of AAR, a stable hemoglobin level was achieved. On control MSCT six months later, there was no sign of malignant disease. Oral ACEi and AAR are appropriate treatment in the control of erythrocytosis in dialysis patients.Bijelac u dobi od 59 godina zapoÄeo je s primjenom hemodijalize s prekidima u ožujku 1995. radi lijeÄenja terminalne bubrežne bolesti nepoznate etiologije. U prosincu 2002. poÄeo je primati parenteralnu željeznu sukrozu, 100 mg svaka dva tjedna, zbog nedostatka željeza. Nije primao eritropoetin. Nakon mjesec dana nastupio je svrbež, a krvne pretrage su ukazale na eritrocitozu. LijeÄenje željezom smjesta je prekinuto i napravljena su eetiri vaÄenja krvi kako bi se izbjegla tromboza AV fistule. ZloÄudna bolest bila je iskljuÄena. OdluÄeno je da se primijeni inhibitor enzima konvertaze angiotenzina (ACEi), ramipril, u dozi od 2,5 mg/dan. MeÄutim, u bolesnika se je razvio težak kaÅ”alj kao nuspojava ramiprila, pa je bolesnik preÅ”ao na terapiju antagonistom tipa II. receptora angiotenzina (AAR), losartanom, u dozi od 25 mg/dan. Za vrijeme dok je bolesnik bio sklon hipotenziji tijekom postupaka dijalize, losartan je dobivao svake veÄeri prije spavanja. Mjesec dana nakon uvoÄenja AAR postignuta je stabilna razina hemoglobina. Kontrolna MSCT nakon Å”est mjeseci nije pokazala nikakvih znakova zloÄudne bolesti. Oralni ACEi i AAR su primjerena terapija za reguliranje eritrocitoze u bolesnika na dijalizi
Cerebellopontine angle tumors
Tumori pontocerebelarnog kuta Äine gotovo desetinu svih intrakranijskih tumora.
Zbog odreÄenih znaÄajki u kliniÄkoj slici i pristupu u lijeÄenju, ove Äe tumore mnogi autori svrstati
u zajedniÄku skupinu patologije u neurokirurgiji. Ove lezije predstavljaju poseban izazov u
dijagnostici i kirurÅ”kom lijeÄenju zbog specifiÄnog anatomskog smjeÅ”taja i vrlo raznolike etiologije.
UnatoÄ svojoj kompleksnosti, a sukladno rezultatima najnovijih kliniÄkih istraživanja, u modernoj
neurokirurgiji oÄekuje se uspjeÅ”no prepoznavanje kao i praÄenje progresije lezija pontocerebelarnog
kuta na temelju kliniÄke slike i visoko specifiÄnih neuroradioloÅ”kih i drugih metoda
diferencijalne dijagnostike. U konaÄnici kirurÅ”ko lijeÄenje dovodi do niskog morbiditeta i zanemarivog
mortaliteta operiranih bolesnika.Cerebellopontine angle tumors comprise almost 10 % of all intracranial tumors.
Due to their distinct clinical features and therapy approaches these tumors are listed within
the same neurosurgery pathological group. Such lesions represent a unique challenge in diagnostics
and surgical treatment which reflects their specific anatomic position and a large variety in etiology.
Despite the complexity of such tumors the most recent clinical research studies indicate
that modern neurosurgery can provide successful recognition and monitoring of cerebellopontine
angle lesion progression based on the clinical features and highly specific neuroradiological
and other diagnostic methods. Surgical treatment results in low morbidity and
minimal mortality rate of patients going through such surgery
Eritrocitoza u bolesnika na hemodijalizi lijeÄenog željeznom sukrozom
A 59-year-old Caucasian male started intermittent hemodialysis in March 1995 for the treatment of end-stage renal disease of unknown etiology. In December 2002, he started receiving parenteral iron sucrose, 100 mg every two weeks, for iron deficiency. He did not receive erythropoietin. One month later he experienced severe pruritus. Blood analysis revealed erythrocytosis. Iron therapy was discontinued immediately, and four venepunctures were performed to avoid thrombosis of AV fistula. Malignant disease was excluded. It was decided to apply an angiotensin convertase enzyme inhibitor (ACEi), ramipril, in a dose of 2.5 mg/day. However, the patient developed severe cough as a side effect of ramipril and was
switched to an angiotensin receptor type II antagonist (AAR), losartan, in a dose of 25 mg/day. While the patient was prone to hypotension during the dialysis sessions, losartan was administered every evening at bedtime. One month after the introduction of AAR, a stable hemoglobin level was achieved. On control MSCT six months later, there was no sign of malignant disease. Oral ACEi and AAR are appropriate treatment in the control of erythrocytosis in dialysis patients.Bijelac u dobi od 59 godina zapoÄeo je s primjenom hemodijalize s prekidima u ožujku 1995. radi lijeÄenja terminalne bubrežne bolesti nepoznate etiologije. U prosincu 2002. poÄeo je primati parenteralnu željeznu sukrozu, 100 mg svaka dva tjedna, zbog nedostatka željeza. Nije primao eritropoetin. Nakon mjesec dana nastupio je svrbež, a krvne pretrage su ukazale na eritrocitozu. LijeÄenje željezom smjesta je prekinuto i napravljena su eetiri vaÄenja krvi kako bi se izbjegla tromboza AV fistule. ZloÄudna bolest bila je iskljuÄena. OdluÄeno je da se primijeni inhibitor enzima konvertaze angiotenzina (ACEi), ramipril, u dozi od 2,5 mg/dan. MeÄutim, u bolesnika se je razvio težak kaÅ”alj kao nuspojava ramiprila, pa je bolesnik preÅ”ao na terapiju antagonistom tipa II. receptora angiotenzina (AAR), losartanom, u dozi od 25 mg/dan. Za vrijeme dok je bolesnik bio sklon hipotenziji tijekom postupaka dijalize, losartan je dobivao svake veÄeri prije spavanja. Mjesec dana nakon uvoÄenja AAR postignuta je stabilna razina hemoglobina. Kontrolna MSCT nakon Å”est mjeseci nije pokazala nikakvih znakova zloÄudne bolesti. Oralni ACEi i AAR su primjerena terapija za reguliranje eritrocitoze u bolesnika na dijalizi
A retrospective study on chronic obstructive pulmonary disease severity and cardiovascular comorbidities
ANALYSIS OF TOBACCO PRODUCTION ON THE FAMILY FARM DUMANÄIÄ FROM 2012 TO 2014
U radu je analizirana proizvodnja duhana za razdoblje od 2012. do 2014. godine. IstraÅ£ivanja o vaÅ£nijim tehnoloÅ”kim Äiniteljima proizvodnje i ekonomskim pokazateljima obavljena su na OPG DumanÄiÄ iz Kutjeva. Cilj istraÅ£ivanja bio je utvrditi tehnoloÅ”ke Äinitelje i izraÄunati ekonomske rezultate u proizvodnji duhana. Temeljem prikupljenih knjigovodstvenih podataka izraÄene su trogodiÅ”nje analitiÄke kalkulacije u kojima su prikazani prihodi, troÅ”kovi i financijski rezultat. ProsjeÄna proizvodnost rada iznosi 5,45 kg po satu, te utroÅ”aka od 561,11 sati po toni. ProsjeÄni koeficijent ekonomiÄnosti proizvodnje iznosi 1,44 iz Äega je vidljivo da je proizvodnja duhana bila ekonomiÄna, a na 100 kn uloÅ£enih u proizvodnju ostvareno je prosjeÄno 44,38 kn dobiti.The paper analyzes the tobacco production in the period from 2012 to 2014. Research on important technological factors of production and economic indicators performed at OPG DumanÄiÄ from Kutjevo. The aim of this study was to determine the technological factors and calculate the economic results in the production of tobacco. Based on the collected accounting dana made a three-year analytical calculations that presents revenues, expenses an financial results. Average labor productivity is 5,45 kg per hour, and the consumption of 561,11 hours per ton. The average coefficient of economic production amounts to 1,44 from which it is clear that tobacco production was economical, and the 100 invested in production realized an average of 44,38 profit